Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'METASTATIC MALIGNANT-MELANOMA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 158 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Agarwala, SS; Sabbagh, MH
      Histamine dihydrochloride: inhibiting oxidants and synergising IL-2-mediated immune activation in the tumour microenvironment

      EXPERT OPINION ON BIOLOGICAL THERAPY
    2. Sileni, VC; Nortilli, R; Aversa, SML; Paccagnella, A; Medici, M; Corti, L; Favaretto, AG; Cetto, GL; Monfardini, S
      Phase II randomized study of dacarbazine, carmustine, cisplatin and tamoxifen versus dacarbazine alone in advanced melanoma patients

      MELANOMA RESEARCH
    3. Kampinga, HH; Dikomey, E
      Hyperthermic radiosensitization: mode of action and clinical relevance

      INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
    4. Kirkwood, JM; Ibrahim, JG; Sosman, JA; Sondak, VK; Agarwala, SS; Ernstoff, MS; Rao, U
      High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: Results of Intergroup trial E1694/S9512/C509801

      JOURNAL OF CLINICAL ONCOLOGY
    5. Kilbridge, KL; Weeks, JC; Sober, AJ; Haluska, FG; Slingluff, CL; Atkins, MB; Sock, DE; Kirkwood, JM; Nease, RF
      Patient preferences for adjuvant interferon alfa-2b treatment

      JOURNAL OF CLINICAL ONCOLOGY
    6. Balch, CM; Buzaid, AC; Soong, SJ; Atkins, MB; Cascinelli, N; Coit, DG; Fleming, ID; Gershenwald, JE; Houghton, A; Kirkwood, JM; McMasters, KM; Mihm, MF; Morton, DL; Reintgen, DS; Ross, MI; Sober, A; Thompson, JA; Thompson, JF
      Final version of the American Joint Committee on Cancer staging system forcutaneous melanoma

      JOURNAL OF CLINICAL ONCOLOGY
    7. Wickremesekera, JK; Chen, WX; Cannan, RJ; Stubbs, RS
      Serum proinflammatory cytokine response in patients with advanced liver tumors following selective internal radiation therapy (SIRT) with (90)yttriummicrospheres

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    8. Falk, MH; Issels, RD
      Hyperthermia in oncology

      INTERNATIONAL JOURNAL OF HYPERTHERMIA
    9. D'Incan, M; Souteyrand, P
      Dacarbazine (Deticene (R))

      ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE
    10. Helmke, BM; Deichmann, M; Otto, HF
      Anorectal melanomas do not harbour the Kaposi sarcoma-associated human herpesvirus type 8 DNA

      JOURNAL OF MEDICAL VIROLOGY
    11. Konjevic, G; Jovic, V; Radulovic, S; Jelic, S; Dzodic, R; Spuzic, I
      Therapeutic implications of the kinetics of immunomodulation during singleor combined treatment of melanoma patients with dacarbazine and interferon-alpha

      NEOPLASMA
    12. Lang, KS; Caroli, CC; Muhm, A; Wernet, D; Moris, A; Schittek, B; Knauss-Scherwitz, E; Stevanovic, S; Rammensee, HG; Garbe, C
      HLA-A2 restricted, melanocyte-specific CD8(+) T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA/MART1

      JOURNAL OF INVESTIGATIVE DERMATOLOGY
    13. Helmbach, H; Rossmann, E; Kern, MA; Schadendorf, D
      Drug-resistance in human melanoma

      INTERNATIONAL JOURNAL OF CANCER
    14. Nashan, D; Luger, TA
      Cytokines - current status and perspectives in the treatment of skin tumors

      HAUTARZT
    15. Waldmann, V; Deichmann, M; Jackel, A
      Melanoma cells in the blood and bone marrow. Clinical importance and identification via potential tumor markers

      HAUTARZT
    16. Mouawad, R; Antoine, EC; Khayat, D; Soubrane, C
      Effect of endogenous interleukin-6 on Fas (APO-1/CD95) receptor expressionin advanced melanoma patients

      CYTOKINES CELLULAR & MOLECULAR THERAPY
    17. Hellstrand, K; Brune, M; Dahlgren, C; Hansson, M; Hermodsson, S; Lindner, P; Mellqvist, UH; Naredi, P
      Alleviating oxidative stress in cancer immunotherapy: a role for histamine?

      MEDICAL ONCOLOGY
    18. Tsang, TC; Brailey, JL; Vasanwala, FH; Wu, RS; Liu, F; Clark, PR; Meade-Tollin, L; Luznick, L; Stopeck, AT; Akporiaye, ET; Harris, DT
      Construction of new amplifier expression vectors for high levels of IL-2 gene expression

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    19. Morris, KT; Marquez, CM; Holland, JM; Vetto, JT
      Prevention of local recurrence after surgical debulking of nodal and subcutaneous melanoma deposits by hypofractionated radiation

      ANNALS OF SURGICAL ONCOLOGY
    20. Hellstrand, K; Hansson, M; Hermodsson, S
      Adjuvant histamine in cancer immunotherapy

      SEMINARS IN CANCER BIOLOGY
    21. Brinckerhoff, LH; Thompson, LW; Slingluff, GL
      Melanoma vaccines

      CURRENT OPINION IN ONCOLOGY
    22. Dreau, D; Foster, M; Hogg, M; Swiggett, J; Holder, WD; White, RL
      Angiogenic and immune parameters during recombinant interferon-alpha 2b adjuvant treatment in patients with melanoma

      ONCOLOGY RESEARCH
    23. Kubo, H; Matsumoto, K; Funahashi, M; Takagi, H; Kitajima, Y; Taniguchi, S; Saida, T
      Sequential chemoimmunotherapy with cisplatin, interferon-beta and interleukin-2 inhibits the growth of B16-F1 melanoma in syngeneic mice

      MELANOMA RESEARCH
    24. Vuoristo, MS; Kellokumpu-Lehtinen, P; Laine, S; Parvinen, LM; Hahka-Kemppinen, M; Korpela, M; Kumpulainen, E
      The value of serum S-100 beta and interleukins as tumour markers in advanced melanoma

      MELANOMA RESEARCH
    25. Nuijen, B; Bouma, M; Manada, C; Jimeno, JM; Schellens, JHM; Bult, A; Beijnen, JH
      Pharmaceutical development of anticancer agents derived from marine sources

      ANTI-CANCER DRUGS
    26. Abel, EA
      Skin neoplasias including cutaneous lymphoma, melanoma, and others: Unapproved treatments or indications

      CLINICS IN DERMATOLOGY
    27. Rau, B; Wust, P; Tilly, W; Gellermann, J; Harder, C; Riess, H; Budach, V; Felix, R; Schlag, PM
      Preoperative radiochemotherapy in locally advanced or recurrent rectal cancer: Regional radiofrequency hyperthermia correlates with clinical parameters

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    28. Kozlowski, L; Wojtukiewicz, MZ; Ostrowska, H
      Cathepsin A activity in primary and metastatic human melanocytic tumors

      ARCHIVES OF DERMATOLOGICAL RESEARCH
    29. Egawa, K; Honda, Y; Kuroki, M; Ono, T
      The carcinoembryonic antigen (CEA) family (CD66) expressed in melanocytic naevi is not expressed in blue naevuscell naevi in dendritic type

      JOURNAL OF CUTANEOUS PATHOLOGY
    30. Schrader, AJ; Probst-Kepper, M; Grosse, J; Kunter, U; Franzke, A; Sel, S; Atzpodien, E; Buer, J
      Tumour microdissemination and survival in metastatic melanoma

      ANTICANCER RESEARCH
    31. Tait, BD
      HLA class I expression on human cancer cells - Implications for effective immunotherapy

      HUMAN IMMUNOLOGY
    32. Gokden, N; Nappi, O; Swanson, PE; Pfeifer, JD; Vollmer, RT; Wick, MR; Humphrey, PA
      Renal cell carcinoma with rhabdoid features

      AMERICAN JOURNAL OF SURGICAL PATHOLOGY
    33. Keilholz, U; Eggermont, AMM
      The emerging role of cytokines in the treatment of advanced melanoma

      ONCOLOGY
    34. Mathers, ME; O'Donnell, M
      Squamous cell carcinoma of skin with a rhabdoid phenotype: a case report

      JOURNAL OF CLINICAL PATHOLOGY
    35. Lin, JC; Hirai, S; Chiang, CL; Hsu, WL; Su, JL; Wang, YJ
      Computer simulation and experimental studies of SAR distributions of interstitial arrays of sleeved-slot microwave antennas for hyperthermia treatment of brain tumors

      IEEE TRANSACTIONS ON MICROWAVE THEORY AND TECHNIQUES
    36. Wakely, PE; Frable, WJ; Kneisl, JS
      Aspiration cytopathology of epithelioid angiosarcoma

      CANCER CYTOPATHOLOGY
    37. Balch, CM; Buzaid, AC; Atkins, MB; Cascinelli, N; Coit, DG; Fleming, ID; Houghton, A; Kirkwood, JM; Mihm, MF; Morton, DL; Reintgen, D; Ross, MI; Sober, A; Soong, SJ; Thompson, JA; Thompson, JF; Gershenwald, JE; McMasters, KM
      A new American Joint Committee on Cancer staging system for cutaneous melanoma

      CANCER
    38. Stevens, G; Thompson, JF; Firth, I; O'Brien, CJ; McCarthy, WH; Quinn, MJ
      Locally advanced melanoma - Results of postoperative hypofractionated radiation therapy

      CANCER
    39. Simmons, DJ; Wharton, SM; Waters, R
      Compartment syndrome complicating metastatic malignant melanoma

      BRITISH JOURNAL OF PLASTIC SURGERY
    40. Brochez, L; Naeyaert, JM
      Serological markers for melanoma

      BRITISH JOURNAL OF DERMATOLOGY
    41. Middleton, MR; Lorigan, P; Owen, J; Ashcroft, L; Lee, SM; Harper, P; Thatcher, N
      A randomized phase III study comparing decarbazine, BCNU, cisplatin and tamoxifen with dacarbazine and interferon in advanced melanoma

      BRITISH JOURNAL OF CANCER
    42. Baluna, R; Vitetta, ES
      An in vivo model to study immunotoxin-induced vascular leak in human tissue

      JOURNAL OF IMMUNOTHERAPY
    43. Roemer, RB
      Engineering aspects of hyperthermia therapy

      ANNUAL REVIEW OF BIOMEDICAL ENGINEERING
    44. Sondak, VK; Liu, PY; Flaherty, LE; Fletcher, WS; Periman, P; Gandara, DR; Taylor, SA; Balcerzak, SP; Meyskens, FL
      A phase II evaluation of all-trans-retinoic acid plus interferon alfa-2a in stage IV melanoma: a Southwest Oncology Group Study

      CANCER JOURNAL FROM SCIENTIFIC AMERICAN
    45. Mouawad, R; Khayat, D; Merle, S; Antoine, EC; Gil-Delgado, M; Soubrane, C
      Is there any relationship between interleukin-6/interleukin-6 receptor modulation and endogenous interleukin-6 release in metastatic malignant melanoma patients treated by biochemotherapy?

      MELANOMA RESEARCH
    46. Ferri, RM; Thomas, P; Tramier, H; Guidicelli, R; Kleisbauer, JP
      Prolonged survival in a patient with metastatic malignant melanoma.

      REVUE DES MALADIES RESPIRATOIRES
    47. Deichmann, M; Benner, A; Bock, M; Jackel, A; Uhl, K; Waldmann, V; Naher, H
      S100-beta, melanoma-inhibiting activity, and lactate dehydrogenase discriminate progressive from nonprogressive American Joint Committee on Cancer stage IV melanoma

      JOURNAL OF CLINICAL ONCOLOGY
    48. Seegenschmiedt, MH; Keilholz, L; Altendorf-Hofmann, A; Urban, A; Schell, H; Hohenberger, W; Sauer, R
      Palliative radiotherapy for recurrent and metastatic malignant melanoma: Prognostic factors for tumor response and long-term outcome: A 20-year experience

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    49. Dahl, O; Dalene, R; Schem, BC; Mella, O
      Status of clinical hyperthermia

      ACTA ONCOLOGICA
    50. Gown, AM
      Immunohistochemical determination of primary sites of carcinomas

      JOURNAL OF HISTOTECHNOLOGY
    51. Moros, EG; Fan, XB; Straube, WL
      Experimental assessment of power and temperature penetration depth controlwith a dual frequency ultrasonic system

      MEDICAL PHYSICS
    52. Hwang, LC; Fein, S; Levitsky, H; Nelson, WG
      Prostate cancer vaccines: Current status

      SEMINARS IN ONCOLOGY
    53. Majeski, J
      Bilateral breast masses as initial presentation of widely metastatic melanoma

      JOURNAL OF SURGICAL ONCOLOGY
    54. Fetsch, PA; Marincola, FM; Filie, A; Hijazi, YM; Kleiner, DE; Abati, A
      Melanoma-associated antigen recognized by T cells (MART-1) - The advent ofa preferred immunocytochemical antibody for the diagnosis of metastatic malignant melanoma with fine-needle aspiration

      CANCER CYTOPATHOLOGY
    55. Nagata, K; Murata, T; Shiga, T; Isoda, H; Tanaka, Y
      Dynamic computed tomography predicts tumor temperature and response to thermoradiotherapy in superficial and subsurface tumors

      CANCER
    56. Hauschild, A; Engel, G; Brenner, W; Glaser, R; Monig, H; Henze, E; Christophers, E
      Predictive value of serum S100B for monitoring patients with metastatic melanoma during chemotherapy and or immunotherapy

      BRITISH JOURNAL OF DERMATOLOGY
    57. Hersey, P
      Advances in management of melanoma

      AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE
    58. NATHAN FE; MASTRANGELO MJ
      SYSTEMIC THERAPY IN MELANOMA

      Seminars in surgical oncology
    59. MCDERMOTT DF; TREHU EG; MIER JW; SORCE D; RAND W; RONAYNE L; KAPPLER K; CLANCY M; KLEMPNER M; ATKINS MB
      A 2-PART PHASE-I TRIAL OF HIGH-DOSE INTERLEUKIN-2 IN COMBINATION WITHSOLUBLE (CHINESE-HAMSTER OVARY) INTERLEUKIN-1 RECEPTOR

      Clinical cancer research
    60. MCDERMOTT DF; TREHU EG; MIER JW; SORCE D; RAND W; RONAYNE L; KAPPLER K; CLANCY M; KLEMPNER M; ATKINS MB
      A 2-PART PHASE-I TRIAL OF HIGH-DOSE INTERLEUKIN-2 IN COMBINATION WITHSOLUBLE (CHINESE-HAMSTER OVARY) INTERLEUKIN-1 RECEPTOR

      Clinical cancer research
    61. HSUEH EC; FAMATIGA E; GUPTA RK; QI K; MORTON DL
      ENHANCEMENT OF COMPLEMENT-DEPENDENT CYTOTOXICITY BY POLYVALENT MELANOMA CELL VACCINE (CANCERVAX) - CORRELATION WITH SURVIVAL

      Annals of surgical oncology
    62. DEMEERLEER GO; VERMEERSCH H; VANEIJKEREN M; LEMMERLING M; CAEMAERT J; DENAEYER B; DELRUE L; MOERMAN M; HUYS J
      PRIMARY SINONASAL MUCOSAL MELANOMA - 3 DIFFERENT THERAPEUTIC APPROACHES TO INOPERABLE LOCAL DISEASE OR RECURRENCE AND A REVIEW OF THE LITERATURE

      Melanoma research
    63. KOHLER S; ROUSE RV; SMOLLER BR
      THE DIFFERENTIAL-DIAGNOSIS OF PAGETOID CELLS IN THE EPIDERMIS

      Modern pathology
    64. STADLER R
      INTERFERONS IN DERMATOLOGY - PRESENT-DAY STANDARD

      Dermatologic clinics
    65. KEILHOLZ U; CONRADT C; LEGHA SS; KHAYAT D; SCHEIBENBOGEN C; THATCHER N; GOEY SH; GORE M; DORVAL T; HANCOCK B; PUNT CJA; DUMMER R; AVRIL MF; BROCKER EB; BENHAMMOUDA A; EGGERMONT AMM; PRITSCH M
      RESULTS OF INTERLEUKIN-2-BASED TREATMENT IN ADVANCED MELANOMA - A CASE RECORD-BASED ANALYSIS OF 631 PATIENTS

      Journal of clinical oncology
    66. MARGOLIN KA; LIU PY; FLAHERTY LE; SOSMAN JA; WALKER MJ; SMITH JW; FLETCHER WS; WEISS GR; UNGER JM; SONDAK VK
      PHASE-II STUDY OF CARMUSTINE, DACARBAZINE, CISPLATIN, AND TAMOXIFEN IN ADVANCED MELANOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY

      Journal of clinical oncology
    67. HIRAKI Y; NAKAJO M; MIYAJI N; TAKESHITA T; CHUREI H; OGITA M
      EFFECTIVENESS OF RF CAPACITIVE HYPERTHERMIA COMBINED WITH RADIOTHERAPY FOR STAGE-III AND STAGE-IV ORO-HYPOPHARYNGEAL CANCERS - A NONRANDOMIZED COMPARISON BETWEEN THERMORADIOTHERAPY AND RADIOTHERAPY

      International journal of hyperthermia
    68. Perry, A; Scheithauer, BW; Stafford, SL; Abell-Aleff, PC; Meyer, FB
      "Rhabdoid" meningioma - An aggressive variant

      AMERICAN JOURNAL OF SURGICAL PATHOLOGY
    69. DUNNE BM; MCNAMARA M; CLYNES M; SHERING SG; LARKIN AM; MORAN E; BARNES C; KENNEDY SM
      MDR1 EXPRESSION IS ASSOCIATED WITH ADVERSE SURVIVAL IN MELANOMA OF THE UVEAL TRACT

      Human pathology
    70. VANWIERINGEN N; KOTTE ANTJ; VANLEEUWEN GMJ; LAGENDIJK JJW; VANDIJK JDP; NIEUWENHUYS GJ
      DOSE UNIFORMITY OF FERROMAGNETIC SEED IMPLANTS IN TISSUE WITH DISCRETE VASCULATURE - A NUMERICAL STUDY ON THE IMPACT OF SEED CHARACTERISTICS AND IMPLANTATION TECHNIQUES

      Physics in medicine and biology
    71. FALKSON CI; FALKSON HC
      PROGNOSTIC FACTORS IN METASTATIC MALIGNANT-MELANOMA - AN ANALYSIS OF 236 PATIENTS TREATED ON CLINICAL RESEARCH STUDIES AT THE DEPARTMENT-OF-MEDICAL-ONCOLOGY, UNIVERSITY-OF-PRETORIA, SOUTH-AFRICA FROM 1972-1992

      Oncology
    72. Dall, P; Wilhelm, OG
      Molecular approaches to gene therapy

      GYNAKOLOGE
    73. DETAKATS PG; WILLIAMS MV; HAWKINS R
      ADJUVANT THERAPY FOR MELANOMA - HOW SHOULD WE RESPOND TO HIGH-DOSE INTERFERON

      British Journal of Cancer
    74. WHOOLEY BP; SHAW P; ASTROW AB; TOTH IR; WALLACK MK
      LONG-TERM SURVIVAL AFTER LOCALLY AGGRESSIVE ANORECTAL MELANOMA

      The American surgeon
    75. HSUEH EC; GUPTA RK; QI K; YEE R; LEOPOLDO ZC; MORTON DL
      TA90 IMMUNE-COMPLEX PREDICTS SURVIVAL FOLLOWING SURGERY AND ADJUVANT VACCINE IMMUNOTHERAPY FOR STAGE-IV MELANOMA

      The cancer journal from Scientific American
    76. KEILHOLZ U; STOTER G; PUNT CJA; SCHEIBENBOGEN C; LEJEUNE F; EGGERMONT AMM
      RECOMBINANT INTERLEUKIN-2-BASED TREATMENTS FOR ADVANCED MELANOMA - THE EXPERIENCE OF THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER MELANOMA COOPERATIVE GROUP

      The cancer journal from Scientific American
    77. OBRIEN CJ; PETERSENSCHAEFER K; STEVENS GN; BASS PC; TEW P; GEBSKI VJ; THOMPSON JF; MCCARTHY WH
      ADJUVANT RADIOTHERAPY FOLLOWING NECK DISSECTION AND PAROTIDECTOMY FORMETASTATIC MALIGNANT-MELANOMA

      Head & neck
    78. SHIGA T; NAGATA K; AKAGI K; SHIRAISHI T; IMAMURA M; TANAKA Y
      LONG-TERM RESULTS OF THERMORADIOTHERAPY FOR SUPERFICIAL, SUBSURFACE TUMORS USING A 430 MHZ MICROWAVE-HEATING SYSTEM

      International journal of oncology
    79. KAMPINGA HH; HIEMSTRA YS; KONINGS AWT; DIKOMEY E
      CORRELATION BETWEEN SLOWLY REPAIRABLE DOUBLE-STRAND BREAKS AND THERMAL RADIOSENSITIZATION IN THE HUMAN HELA S3 CELL-LINE

      International journal of radiation biology
    80. KRUIT WHJ; STOTER G
      THE ROLE OF ADOPTIVE IMMUNOTHERAPY IN SOLID CANCERS

      Netherlands journal of medicine
    81. AKYUREKLI D; GERIG LH; RAAPHORST GP
      CHANGES IN MUSCLE BLOOD-FLOW DISTRIBUTION DURING HYPERTHERMIA

      International journal of hyperthermia
    82. BODEY B; BODEY B; KAISER HE
      IMMUNOCYTOCHEMICAL DETECTION OF PROSTATE-SPECIFIC ANTIGEN EXPRESSION IN HUMAN PRIMARY AND METASTATIC MELANOMAS

      Anticancer research
    83. BODEY B; BODEY B; GROGER AM; SIEGEL SE; KAISER HE
      NM23 NUCLEOSIDE DIPHOSPHATE (NDP) KINASE EXPRESSION IN HUMAN-MALIGNANT MELANOMAS - SIGNIFICANCE AND IMPLICATIONS IN TUMOR BIOLOGY/

      Anticancer research
    84. BALUNA R; VITETTA ES
      VASCULAR LEAK SYNDROME - A SIDE-EFFECT OF IMMUNOTHERAPY

      Immunopharmacology
    85. SKEEL RT; QUAN WDY; PALACKDHARRY CS
      COMMON CANCERS - IMMUNOTHERAPY AND MULTIDISCIPLINARY THERAPY .3. IMMUNOTHERAPY FOR CANCER - HARNESSING THE HOST IMMUNE DEFENSES - BIOLOGIC MECHANISMS AND RESULTS IN MELANOMA AND RENAL CELL CARCINOMA .4. MULTIDISCIPLINARY THERAPY OF BREAST, COLORECTAL, AND LUNG CANCER

      Disease-a-month
    86. ANBARI KK; SCHUCHTER LM; BUCKY LP; MICK R; SYNNESTVEDT M; GUERRY D; HAMILTON B; HALPERN AC
      MELANOMA OF UNKNOWN PRIMARY SITE - PRESENTATION, TREATMENT, AND PROGNOSIS - A SINGLE INSTITUTION STUDY

      Cancer
    87. BRAND CU; ELLWANGER U; STROEBEL W; MEIER F; SCHLAGENHAUFF B; RASSNER G; GARBE C
      PROLONGED SURVIVAL OF 2 YEARS OR LONGER FOR PATIENTS WITH DISSEMINATED MELANOMA - AN ANALYSIS OF RELATED PROGNOSTIC FACTORS

      Cancer
    88. WOLL PJ; PETTENGELL R
      INTERFERONS IN ONCOLOGY

      British journal of clinical practice
    89. BUER J; PROBST M; FRANZKE A; DUENSING S; HAINDL J; VOLKENANDT M; WITTKE F; HOFFMANN R; GANSER A; ATZPODIEN J
      ELEVATED SERUM LEVELS OF S100 AND SURVIVAL IN METASTATIC MALIGNANT-MELANOMA

      British Journal of Cancer
    90. NEIFELD JP
      ENDOCRINOLOGY OF MELANOMA

      Seminars in surgical oncology
    91. BEAR HD; HAMAD GG; KOSTUCHENKO PJ
      BIOLOGIC THERAPY OF MELANOMA WITH CYTOKINES AND LYMPHOCYTES

      Seminars in surgical oncology
    92. LUTHER H; LUBOWIETZKI M; ROCHLING A; KISSLER M; ALTMEYER P
      LONG-TERM SURVIVAL OF METASTATIC MELANOMA AFTER REPEATED SURGICAL INTERVENTIONS

      EJD. European journal of dermatology
    93. PELLEGRINI P; BERGHELLA AM; DELBEATO T; ADORNO D; CASCIANI CU
      IMMUNOLOGICAL DIRECTIVES FOR BIOTHERAPY IMPROVEMENT IN THE TREATMENT OF COLORECTAL-CANCER

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    94. TREHU EG; MIER JW; DUBOIS JS; SORCE D; KLEMPNER MS; EPSTEIN M; DINARELLO CA; SHAPIRO L; KAPPLER K; RONAYNE L; ATKINS MB
      PHASE-I TRIAL OF INTERLEUKIN-2 IN COMBINATION WITH THE SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTOR P75 IGG CHIMERA

      Clinical cancer research
    95. GAUSE BL; SZNOL M; KOPP WC; JANIK JE; SMITH JW; STEIS RG; URBA WJ; SHARFMAN W; FENTON RG; CREEKMORE SP; HOLMLUND J; CONLON KC; VANDERMOLEN LA; LONGO DL
      PHASE-I STUDY OF SUBCUTANEOUSLY ADMINISTERED INTERLEUKIN-2 IN COMBINATION WITH INTERFERON ALFA-2A IN PATIENTS WITH ADVANCED CANCER

      Journal of clinical oncology
    96. TARTOUR E; BLAY JY; DORVAL T; ESCUDIER B; MOSSERI V; DOUILLARD JY; DENEUX L; GORIN I; NEGRIER S; MATHIOT C; POUILLART P; FRIDMAN WH
      PREDICTORS OF CLINICAL-RESPONSE TO INTERLEUKIN-2-BASED IMMUNOTHERAPY IN MELANOMA PATIENTS - A FRENCH MULTIINSTITUTIONAL STUDY

      Journal of clinical oncology
    97. PAPAC RJ
      SPONTANEOUS REGRESSION OF CANCER

      Cancer treatment reviews
    98. FLAHERTY LE; LIU PY; MITCHELL MS; FLETCHER WS; WALKER MJ; GOODWIN JW; STEPHENS RL; SONDAK VK
      THE ADDITION OF TAMOXIFEN TO DACARBAZINE AND CISPLATIN IN METASTATIC MALIGNANT-MELANOMA - A PHASE-II TRIAL OF THE SOUTHWEST ONCOLOGY GROUP (SWOG-8921)

      American journal of clinical oncology
    99. ENGIN K
      BIOLOGICAL RATIONALE AND CLINICAL-EXPERIENCE WITH HYPERTHERMIA

      Controlled clinical trials
    100. KLAUS MV; SHAH F
      GENERALIZED MELANOSIS CAUSED BY MELANOMA OF THE RECTUM

      Journal of the American Academy of Dermatology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 01/11/20 alle ore 03:36:25